Mela Sciences (MELA -7.6%) trades lower today after the company gave its presentation at Needham's Growh Conference yesterday, saying it plans to restructure its manufacturing operations this year to "significantly reduce manufacturing costs" of MelaFind, its hand-held device identifying possible melanoma, in an effort to relieve pressure on its margins.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs